GCA HealthCare Consulting Congratulates Rna Diagnostics Inc. and Medtronic of...
Rna Diagnostics’s innovative RDA™ Cancer Chemotherapy Guidance Assay and Medtronic’s leading edge Symplicty™ Renal Denervation System are considered disruptive technologies and were selected as lead projects for MaRS EXCITE. GCA HealthCare Consulting has provided specialized consultancy services to both firms…